An update review of the application of single-cell RNA sequencing in pregnancy-related diseases
2024

Single-Cell RNA Sequencing in Pregnancy-Related Diseases

publication Evidence: high

Author Information

Author(s): Zhou Zhiyi, Yang Xiuhua

Primary Institution: Department of Obstetrics, The First Hospital of China Medical University, Shenyang, China

Hypothesis

Single-cell RNA sequencing (scRNA-seq) can provide insights into the cellular mechanisms underlying pregnancy-related diseases.

Conclusion

scRNA-seq is a crucial tool for studying the etiology of pregnancy complications and can improve diagnosis and treatment.

Supporting Evidence

  • scRNA-seq allows for the identification of rare cell types in the placenta.
  • Studies have shown that scRNA-seq can capture various cell types and their origins.
  • scRNA-seq has been used to explore the mechanisms of pregnancy complications like preeclampsia and recurrent pregnancy loss.

Takeaway

Scientists are using a special technique called single-cell RNA sequencing to learn more about how pregnancy works and what can go wrong.

Methodology

The review discusses various studies utilizing scRNA-seq to analyze placental tissues and maternal-fetal interactions across different pregnancy complications.

Potential Biases

Potential biases may arise from sample collection methods and the timing of tissue acquisition.

Limitations

Challenges include obtaining representative samples and ethical concerns regarding the use of human placentas.

Digital Object Identifier (DOI)

10.3389/fendo.2024.1415173

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication